BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 34635167)

  • 1. Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6.
    Solomon A; Stephen R; Altomare D; Carrera E; Frisoni GB; Kulmala J; Molinuevo JL; Nilsson P; Ngandu T; Ribaldi F; Vellas B; Scheltens P; Kivipelto M;
    Alzheimers Res Ther; 2021 Oct; 13(1):171. PubMed ID: 34635167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trials and Treatments for Vascular Brain Health: Risk Factor Modification and Cognitive Outcomes.
    Kivipelto M; Palmer K; Hoang TD; Yaffe K
    Stroke; 2022 Feb; 53(2):444-456. PubMed ID: 35000424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multidomain interventions for risk reduction and prevention of cognitive decline and dementia: current developments.
    Röhr S; Kivipelto M; Mangialasche F; Ngandu T; Riedel-Heller SG
    Curr Opin Psychiatry; 2022 Jul; 35(4):285-292. PubMed ID: 35703256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.
    McMaster M; Kim S; Clare L; Torres SJ; D'Este C; Anstey KJ
    Clin Interv Aging; 2018; 13():2397-2406. PubMed ID: 30538436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Domain Interventions for Dementia Prevention - A Systematic Review.
    Castro CB; Costa LM; Dias CB; Chen J; Hillebrandt H; Gardener SL; Brown BM; Loo RL; Garg ML; Rainey-Smith SR; Martins RN; Sohrabi HR
    J Nutr Health Aging; 2023; 27(12):1271-1280. PubMed ID: 38151879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.
    Sherman DS; Mauser J; Nuno M; Sherzai D
    Neuropsychol Rev; 2017 Dec; 27(4):440-484. PubMed ID: 29282641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidomain Interventions to Prevent Cognitive Impairment, Alzheimer's Disease, and Dementia: From FINGER to World-Wide FINGERS.
    Rosenberg A; Mangialasche F; Ngandu T; Solomon A; Kivipelto M
    J Prev Alzheimers Dis; 2020; 7(1):29-36. PubMed ID: 32010923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of the First WHO Guidelines for Risk Reduction of Cognitive Decline and Dementia: Lessons Learned and Future Directions.
    Stephen R; Barbera M; Peters R; Ee N; Zheng L; Lehtisalo J; Kulmala J; Håkansson K; Chowdhary N; Dua T; Solomon A; Anstey KJ; Kivipelto M
    Front Neurol; 2021; 12():763573. PubMed ID: 34764935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial.
    Deckers K; Zwan MD; Soons LM; Waterink L; Beers S; van Houdt S; Stiensma B; Kwant JZ; Wimmers SCPM; Heutz RAM; Claassen JAHR; Oosterman JM; de Heus RAA; van de Rest O; Vermeiren Y; Voshaar RCO; Smidt N; Broersen LM; Sikkes SAM; Aarts E; ; ; Köhler S; van der Flier WM
    Alzheimers Res Ther; 2024 Jun; 16(1):126. PubMed ID: 38872204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review.
    Coley N; Giulioli C; Aisen PS; Vellas B; Andrieu S
    Ageing Res Rev; 2022 Dec; 82():101777. PubMed ID: 36336171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol.
    Barbera M; Lehtisalo J; Perera D; Aspö M; Cross M; De Jager Loots CA; Falaschetti E; Friel N; Luchsinger JA; Gavelin HM; Peltonen M; Price G; Neely AS; Thunborg C; Tuomilehto J; Mangialasche F; Middleton L; Ngandu T; Solomon A; Kivipelto M;
    Alzheimers Res Ther; 2024 Jan; 16(1):23. PubMed ID: 38297399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia.
    Kwan J; Hafdi M; Chiang LLW; Myint PK; Wong LS; Quinn TJ
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012269. PubMed ID: 35833913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial.
    Rosenberg A; Ngandu T; Rusanen M; Antikainen R; Bäckman L; Havulinna S; Hänninen T; Laatikainen T; Lehtisalo J; Levälahti E; Lindström J; Paajanen T; Peltonen M; Soininen H; Stigsdotter-Neely A; Strandberg T; Tuomilehto J; Solomon A; Kivipelto M
    Alzheimers Dement; 2018 Mar; 14(3):263-270. PubMed ID: 29055814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidomain lifestyle interventions for cognition and the risk of dementia: A systematic review and meta-analysis.
    Meng X; Fang S; Zhang S; Li H; Ma D; Ye Y; Su J; Sun J
    Int J Nurs Stud; 2022 Jun; 130():104236. PubMed ID: 35395572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MyCOACH (COnnected Advice for Cognitive Health): a digitally delivered multidomain intervention for cognitive decline and risk of dementia in adults with mild cognitive impairment or subjective cognitive decline-study protocol for a randomised controlled trial.
    Amos JG; Zheng L; Eramudugolla R; Parekh D; Huque MH; Delbaere K; Lautenschlager N; Anstey KJ
    BMJ Open; 2023 Oct; 13(10):e075015. PubMed ID: 37903606
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.